GAM Holding’s CONMED CNMD Stock Holding History

GAM Holding’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,802	Closed	-$325K	–	818
2019 Q2	$325K	Sell	3,802 -666	-15%	-$54.7K	0.01%	762
2019 Q1	$372K	Buy	+4,468	New	+$325K	0.02%	691

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

GAM Holding's CNMD Position: Q3 2019 in Review

GAM Holding sold out of CONMED (CNMD) in Q3 2019, closing a stake of 3,802 shares — an estimated $325K sold.

GAM Holding first reported a position in CNMD in Q1 2019 and held it in 2 quarters. The position peaked at $372K in Q1 2019. 234 funds tracked by Wall St. Rank hold CNMD as of Q3 2019.

GAM Holding reported no remaining CONMED position as of Q3 2019 after selling out during the quarter.
GAM Holding sold 3,802 CONMED shares in Q3 2019, an estimated $325K.
GAM Holding first reported a position in CONMED in Q1 2019 and held it in 2 quarters.
GAM Holding's CONMED position peaked at $372K in Q1 2019.
234 funds tracked by Wall St. Rank held CONMED as of Q3 2019.

Based on GAM Holding's 13F filing for Q3 2019, filed 8 Nov 2019.